Lupin has appointed Theresa Stevens as chief corporate development officer for its global operations.
Stevens joins the India-based pharma company from Aptalis Pharma, where she was chief corporate development officer for mergers and acquisitions, strategy and global business development.
Prior to this Steven spent nine years at Novartis, serving in such roles as head of global business development and licensing.
She holds degrees in both biochemisty and law, and has previously worked as a research scientist at Dupont and as a lawyer at Pennie & Edmonds.
Lupin’s decision to hire Stevens follows its appointment earlier this year of Teva’s Dr Maurice Chagnaud as president, Europe, and head of inhalation strategy.
According to the company, these hires are part of a push to expand the company beyond its home market by improving its performance in the US, Europe and key emerging markets.